Skip to content
Clinical Trials – home
BelgiumBack to Belgium

Clinical trials in Brussels – page 82

2 059 clinical trials in Brussels, Belgium across 6 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Brussels at a glance
2 059
clinical trials
  • Research sites6
Type of trial
Recruitment status
Quick filters

2 059 trials in Brussels

Open in trial search

Hidradenitis

Not recruiting

Study on the Effects of Sonelokimab for Adults with Moderate to Severe Hidradenitis Suppurativa

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Sonelokimab
  • Sponsor:MoonLake Immunotherapeutics AG

Coeliac disease

Not recruiting

Study on the Effects of Amlitelimab for Adults with Non-Responsive Celiac Disease

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Amlitelimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Crohn's disease

Not recruiting

Study on the Effects of Etrasimod Arginine for Patients with Moderate to Severe Crohn's Disease

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Sponsor:Arena Pharmaceuticals Inc.

Neurodermatitis

Not recruiting

Study on the Long-Term Safety and Effectiveness of Nemolizumab for Patients with Prurigo Nodularis

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Nemolizumab
  • Sponsor:Galderma S.A.

Study of trastuzumab deruxtecan treatment in patients with advanced HER2-positive breast cancer with or without brain metastases

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Trastuzumab Deruxtecan
  • Sponsor:Astrazeneca AB

Hypertriglyceridaemia

Not recruiting

Study of Plozasiran for Adults with Severe Hypertriglyceridemia

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Sponsor:Arrowhead Pharmaceuticals Inc.

Colitis ulcerative

Not recruiting

Study on Long-Term Safety of Etrasimod Arginine for Patients with Moderately to Severely Active Ulcerative Colitis

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Sponsor:Arena Pharmaceuticals Inc.

Ovarian cancer

Not recruiting

Study on the Effectiveness of Durvalumab, Olaparib, and Bevacizumab in Patients with Newly Diagnosed Advanced Ovarian Cancer

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Astrazeneca AB

Study on BHV-7000 for Patients with Generalized Tonic-clonic Seizures in Idiopathic Generalized Epilepsy

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:BHV-7000
  • Sponsor:Biohaven Therapeutics Ltd.

Study of Obexelimab Treatment for Adults with Systemic Lupus Erythematosus (SLE)

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Obexelimab
  • Sponsor:Zenas Biopharma (USA) LLC

Study on the Effectiveness and Safety of Polatuzumab Vedotin, Rituximab, and CHP in Patients with Untreated Diffuse Large B-Cell Lymphoma

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Polatuzumab Vedotin
  • Sponsor:F. Hoffmann-La Roche AG

Crohn's disease

Not recruiting

Study on the Safety and Effectiveness of AZD7798 for Adults with Ileal Crohn's Disease and an Ileostomy

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:AZD7798
  • Sponsor:Astrazeneca AB

Other cities in Belgium

The busiest research cities in the country

All 164 cities in Belgium

Clinical research in Brussels

What the registry says about research in the country

01 Oncology

In Bruxelles, several trials focus on neoplasms, especially breast cancer, colorectal cancer, lung cancer, glioblastoma, soft tissue sarcoma, and other advanced solid tumors. These studies are designed to test new treatment combinations, improve survival outcomes, and refine more personalized care for people with difficult-to-treat cancers.

  • ER-positive, HER2-negative breast cancer and related high-risk disease
  • EGFR-mutated non-small cell lung cancer and metastatic lung disease
  • Glioblastoma and other advanced brain tumors
  • Colon cancer, rectal cancer with liver metastasis, and broader advanced solid tumors

Much of this research aims to evaluate whether new therapeutic approaches can better control tumor growth and extend disease-free or overall survival.

02 Neurology and Stroke Care

Clinical trial activity in Bruxelles also includes nervous system diseases, with a strong focus on acute ischemic stroke and intracerebral haemorrhage. The main goal is to improve recovery after stroke and assess safer, more effective treatment strategies in urgent care settings.

  • Acute ischemic stroke with incomplete reperfusion
  • Stroke in patients with recent direct oral anticoagulant use
  • Intracerebral haemorrhage and prevention of later vascular events

These studies are centered on improving functional outcomes, supporting better reperfusion, and understanding how to optimize care after a stroke.

03 Respiratory and Critical Care Medicine

Research in respiratory tract diseases is active, particularly for pneumonia and severe infections requiring hospital or intensive care support. The trials are examining ways to reduce complications, improve recovery, and measure whether new add-on treatments can make standard care more effective.

  • Severe community-acquired pneumonia
  • Hospital-acquired pneumonia
  • Severe pneumonia in critically ill patients

This area includes efforts to test supportive treatments that may help improve survival and shorten the time patients spend in hospital.

04 Cardiovascular and Acute Care Research

Trials in cardiovascular diseases are studying conditions such as cardiogenic shock and other severe acute cardiac or circulatory emergencies. The research is focused on evaluating treatment effectiveness and safety in life-threatening situations where rapid decision-making is essential.

  • Cardiogenic shock linked to acute coronary syndrome
  • Cardiogenic shock of septic origin
  • Cardiogenic shock due to acute decompensated heart failure

These studies aim to provide reliable evidence on outcomes such as mortality and time to hospital discharge.

05 Dermatology and Viral Infections

A distinct group of studies addresses immune system diseases and virus diseases, with work on psoriasis, human papillomavirus, Epstein-Barr virus, and non genital warts. The research is designed to assess symptom improvement, infection clearance, and the longer-term safety of treatment options.

  • Moderate to severe plaque psoriasis
  • HPV infection and genital wart disease
  • Epstein-Barr virus infection
  • Non genital warts

These trials reflect a mix of symptom-focused and infection-focused research in common yet persistent conditions.

06 Infectious Disease and Antiviral Research

Bruxelles is also hosting studies in bacterial infections and mycoses as well as chronic viral disease, including HIV. The emphasis is on improving clinical outcomes, supporting recovery, and testing therapies that may better control infection-related complications.

  • HIV in patients with suppressed viral load
  • Hospital-acquired and severe respiratory infections
  • Viral and skin infections associated with HPV and EBV

This area combines prevention, symptom control, and treatment-response research across several infection types.

07 Breast Cancer and Personalized Treatment

Several trials are specifically focused on breast cancer, including early-stage, locally advanced, and metastatic disease. The research explores more individualized treatment strategies, including approaches guided by tumor biology and relapse risk.

  • ER-positive, HER2-negative breast carcinoma
  • Premenopausal high-risk HR-positive breast cancer
  • High-risk relapse after initial breast cancer treatment

These studies are intended to help match treatment intensity more closely to a patient’s risk profile and tumor characteristics.

08 Gastrointestinal Oncology

Research in digestive system diseases includes studies of colon cancer and rectal cancer, with special attention to older adults and patients with higher recurrence risk. The main goal is to compare treatment strategies that may improve long-term cancer control.

  • Stage III colon cancer
  • Upper rectal cancer
  • Colon and rectal cancer with liver metastasis

This work explores how postoperative treatment choices can support better relapse-free survival and overall disease management.

09 Metabolic and Autoimmune-Related Treatment Safety

Another research stream addresses longer-term treatment safety in immune system diseases, especially for chronic inflammatory conditions. In the city of Bruxelles, investigators are comparing whether newer therapies can maintain effectiveness while reducing health risks over time.

  • Moderate-to-severe plaque psoriasis
  • Cardiovascular safety in long-term treatment use
  • Comparative treatment safety in chronic inflammatory disease

These trials are aimed at supporting safer long-term management for people living with chronic conditions.

10 Not Otherwise Specified / Mixed Oncology Research

Some trials cannot be neatly placed into a single therapeutic category, but they still contribute to the broader oncology and clinical research landscape. These studies often focus on evaluating new treatment options for patients with limited standard choices.

  • Participants with advanced solid tumors
  • Metastatic or advanced cancer populations
  • Recurrent glioblastoma and other hard-to-treat disease settings

The common aim is to test whether emerging therapies can offer meaningful benefit where current options remain limited.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.